StageZero Historical Income Statement
| SZLS Stock | CAD 0.04 0.00 0.00% |
Historical analysis of StageZero Life income statement accounts such as Other Operating Expenses of 13.9 M, Total Operating Expenses of 5.6 M, Income Tax Expense of 4 M or Research Development of 91.1 K can show how well StageZero Life Sciences performed in making a profits. Evaluating StageZero Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of StageZero Life's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining StageZero Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether StageZero Life Sciences is a good buy for the upcoming year.
StageZero |
About StageZero Income Statement Analysis
StageZero Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to StageZero Life shareholders. The income statement also shows StageZero investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
StageZero Life Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of StageZero Life Sciences. It is also known as StageZero Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Most accounts from StageZero Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into StageZero Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in StageZero Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, StageZero Life's Other Operating Expenses is very stable compared to the past year. As of the 1st of December 2024, Income Tax Expense is likely to grow to about 4 M, while Interest Expense is likely to drop about 324.1 K.
| 2023 | 2024 (projected) | Reconciled Depreciation | 283.0K | 377.5K | Interest Income | 1.8M | 1.4M |
StageZero Life income statement Correlations
Click cells to compare fundamentals
StageZero Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
StageZero Life income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 803.2K | 320.4K | 200.3K | 284.1K | 325.3K | 324.1K | |
| Selling General Administrative | 4.2M | 4.0M | 7.0M | 5.9M | 4.1M | 3.0M | |
| Total Revenue | 138.7K | 4.2M | 5.1M | 3.8M | 2.9M | 1.7M | |
| Gross Profit | (960.9K) | 695.6K | 1.2M | (403.7K) | 10.4K | 9.8K | |
| Other Operating Expenses | 5.3M | 7.5M | 13.2M | 11.5M | 13.3M | 13.9M | |
| Operating Income | (5.1M) | (3.7M) | (8.1M) | (7.7M) | (4.6M) | (4.8M) | |
| Ebit | (5.1M) | (3.7M) | (8.1M) | (11.2M) | (10.1M) | (9.6M) | |
| Ebitda | (4.8M) | (3.5M) | (7.6M) | (10.8M) | (9.7M) | (9.2M) | |
| Total Operating Expenses | 4.2M | 4.1M | 9.3M | 7.3M | 7.5M | 5.6M | |
| Net Income | (4.3M) | (7.2M) | (7.7M) | (11.4M) | (12.5M) | (11.9M) | |
| Income Tax Expense | 830.5K | 320.4K | 200.3K | 3.3M | 3.8M | 4.0M | |
| Income Before Tax | (3.5M) | (6.9M) | (7.5M) | (11.4M) | (12.5M) | (11.9M) | |
| Total Other Income Expense Net | 1.5M | (3.1M) | 479.2K | (3.7M) | (7.5M) | (7.2M) | |
| Depreciation And Amortization | 298.1K | 216.3K | 509.3K | 437.4K | 393.7K | 343.3K | |
| Cost Of Revenue | 1.1M | 3.5M | 3.9M | 4.2M | 2.9M | 2.3M | |
| Net Income From Continuing Ops | (3.5M) | (6.9M) | (7.5M) | (11.4M) | (12.5M) | (11.9M) | |
| Net Income Applicable To Common Shares | (3.5M) | (6.9M) | (7.5M) | (11.4M) | (10.3M) | (9.8M) | |
| Net Interest Income | (803.2K) | (664.3K) | (200.3K) | (284.1K) | (390.2K) | (409.7K) | |
| Reconciled Depreciation | 298.1K | 216.3K | 509.3K | 437.4K | 283.0K | 377.5K |
Pair Trading with StageZero Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if StageZero Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in StageZero Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to StageZero Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace StageZero Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back StageZero Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling StageZero Life Sciences to buy it.
The correlation of StageZero Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as StageZero Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if StageZero Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for StageZero Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in StageZero Stock
StageZero Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to StageZero Life shareholders. The income statement also shows StageZero investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).